0000088053-16-002295.txt : 20160726 0000088053-16-002295.hdr.sgml : 20160726 20160726120839 ACCESSION NUMBER: 0000088053-16-002295 CONFORMED SUBMISSION TYPE: N-Q PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20160531 FILED AS OF DATE: 20160726 DATE AS OF CHANGE: 20160726 EFFECTIVENESS DATE: 20160726 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DEUTSCHE INTERNATIONAL FUND, INC. CENTRAL INDEX KEY: 0000088053 IRS NUMBER: 132827803 FISCAL YEAR END: 0331 FILING VALUES: FORM TYPE: N-Q SEC ACT: 1940 Act SEC FILE NUMBER: 811-00642 FILM NUMBER: 161783662 BUSINESS ADDRESS: STREET 1: 345 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10154-0004 BUSINESS PHONE: 212-454-6778 MAIL ADDRESS: STREET 1: 345 PARK AVENUE CITY: NEW YORK STATE: NY ZIP: 10154-0004 FORMER COMPANY: FORMER CONFORMED NAME: DWS INTERNATIONAL FUND, INC. DATE OF NAME CHANGE: 20060207 FORMER COMPANY: FORMER CONFORMED NAME: SCUDDER INTERNATIONAL FUND INC DATE OF NAME CHANGE: 19920703 FORMER COMPANY: FORMER CONFORMED NAME: SCUDDER INTERNATIONAL INVESTMENTS LTD DATE OF NAME CHANGE: 19761203 0000088053 S000006030 Deutsche CROCI International Fund C000016568 Class A SUIAX C000016571 Class C SUICX C000016572 Class S SCINX C000016573 Institutional Class SUIIX C000149477 Class R6 SUIRX N-Q 1 nq053116int_cint.htm DEUTSCHE CROCI INTERNATIONAL FUND

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 

FORM N-Q

QUARTERLY SCHEDULE OF PORTFOLIO HOLDINGS OF REGISTERED

MANAGEMENT INVESTMENT COMPANY

_______________________________

Investment Company Act file number: 811-00642

Deutsche International Fund, Inc.

(Exact name of registrant as specified in charter)

 

345 Park Avenue
New York, NY 10154

(Address of principal executive offices) (Zip code)

 

Paul Schubert

60 Wall Street

New York, NY 10005

(Name and address of agent for service)

Registrant's telephone number, including area code: (212) 250-3220

Date of fiscal year end: 8/31

Date of reporting period: 5/31/2016

 

ITEM 1. SCHEDULE OF INVESTMENTS

 

Investment Portfolio                                         as of May 31, 2016 (Unaudited)

 

 

Deutsche CROCI® International Fund

 

 

  Shares   Value ($)
  Common Stocks 99.2%
France 3.8%
Cie Generale des Etablissements Michelin (a)   321,569   32,680,889
Sanofi (a)   403,405   33,075,660
(Cost $73,538,686)   65,756,549
Germany 4.0%
Continental AG     156,854   33,648,159
Siemens AG (Registered)     326,037   35,112,040
(Cost $70,251,657)   68,760,199
Hong Kong 7.9%
CLP Holdings Ltd.     3,695,746   34,813,706
HK Electric Investments & HK Electric Investments Ltd. "SS", 144A, (Units) (a)   38,650,500   33,921,618
Hong Kong & China Gas Co., Ltd.     18,428,436   35,335,546
MTR Corp., Ltd.     6,963,178   32,975,575
(Cost $133,975,460)   137,046,445
Japan 23.9%
Astellas Pharma, Inc.     2,523,500   34,570,366
Bridgestone Corp.     917,740   31,708,793
Citizen Holdings Co., Ltd.     6,053,900   33,950,168
Denso Corp.     888,649   35,061,250
Isuzu Motors Ltd.     3,159,868   38,123,300
JGC Corp.     2,006,094   31,032,998
Mitsubishi Electric Corp.     3,153,584   38,147,160
Osaka Gas Co., Ltd.     9,521,000   35,767,698
Secom Co., Ltd.     447,300   35,081,957
Tokyo Gas Co., Ltd.     7,787,000   31,496,792
Toyota Industries Corp.     776,518   33,694,577
Toyota Motor Corp.     668,100   34,890,706
(Cost $457,056,945)   413,525,765
Netherlands 1.9%
Koninklijke DSM NV  (Cost $34,589,719)   562,713   33,490,237
Singapore 3.7%
Keppel Corp., Ltd.     8,513,905   33,261,789
Singapore Airlines Ltd.     4,089,982   31,719,561
(Cost $94,409,428)   64,981,350
Spain 3.8%
Gas Natural SDG SA     1,656,894   32,796,640
Iberdrola SA     4,895,726   33,206,320
(Cost $75,862,890)   66,002,960
Sweden 1.9%
Telefonaktiebolaget LM Ericsson "B"  (Cost $50,014,564)   4,205,969   32,422,067
Switzerland 19.5%
ABB Ltd. (Registered)*     1,646,231   34,249,554
Adecco Group AG (Registered)     523,117   31,708,047
Cie Financiere Richemont SA (Registered)     519,090   30,576,177
Kuehne + Nagel International AG (Registered)     241,684   33,991,371
Nestle SA (Registered)     465,033   34,339,459
Novartis AG (Registered)     450,734   35,777,578
Roche Holding AG (Genusschein)     136,331   35,783,459
Sika AG (Bearer)     8,228   35,593,964
Swatch Group AG (Bearer) (a)   102,199   30,125,057
Wolseley PLC     609,551   35,763,970
(Cost $356,260,860)   337,908,636
United Kingdom 28.8%
BAE Systems PLC     4,930,553   34,534,673
Barratt Developments PLC     4,423,334   37,926,683
Bunzl PLC     1,162,958   34,428,520
easyJet PLC     1,575,176   34,973,949
ITV PLC     10,577,962   32,908,623
National Grid PLC     2,447,578   35,697,634
Next PLC     463,378   36,509,656
Persimmon PLC     1,193,792   36,344,174
Rexam PLC     3,775,928   34,371,811
Rolls-Royce Holdings PLC*     311,220,832   450,757
Severn Trent PLC     1,070,130   35,524,222
SSE PLC     1,566,903   34,767,567
Taylor Wimpey PLC     12,754,628   37,943,873
Travis Perkins PLC     1,278,195   35,599,986
Whitbread PLC     594,813   36,286,263
(Cost $545,482,517)   498,268,391
Total Common Stocks (Cost $1,891,442,726)   1,718,162,599
  Securities Lending Collateral 2.6%
Daily Assets Fund "Capital Shares", 0.48% (b) (c) (Cost $45,144,122)     45,144,122   45,144,122
  % of
Net Assets
  Value ($)
Total Investment Portfolio (Cost $1,936,586,848) † 101.8   1,763,306,721
Other Assets and Liabilities, Net (1.8)   (30,608,926)
Net Assets 100.0   1,732,697,795
                   

 

For information on the Fund's policies regarding the valuation of investments and other significant accounting policies, please refer to the Fund's most recent semi-annual or annual financial statements.

 

* Non-income producing security.
The cost for federal income tax purposes was $1,939,273,532.  At May 31, 2016, net unrealized depreciation for all securities based on tax cost was $175,966,811.  This consisted of aggregate gross unrealized appreciation for all securities in which there was an excess of value over tax cost of $23,761,303 and aggregate gross unrealized depreciation for all securities in which there was an excess of tax cost over value of $199,728,114.
(a) All or a portion of these securities were on loan. In addition, "Other Assets and Liabilities, Net" may include pending sales that are also on loan. The value of securities loaned at May 31, 2016 amounted to $42,456,228, which is 2.5% of net assets.
(b) Affiliated fund managed by Deutsche Investment Management Americas Inc.  The rate shown is the annualized seven-day yield at period end.
(c) Represents collateral held in connection with securities lending.  Income earned by the Fund is net of borrower rebates.

 

144A: Security exempt from registration under Rule 144A of the Securities Act of 1933. These securities may be resold in transactions exempt from registration, normally to qualified institutional buyers.
At May 31, 2016, the Fund had the following open forward foreign currency exchange contracts:

 

Contracts to Deliver   In Exchange For   Settlement
Date
   Unrealized
Appreciation ($)
   Counterparty
CHF   300,727,997   USD   303,357,705   6/30/2016   357,205   Morgan Stanley
EUR   213,646,711   USD   238,251,344   6/30/2016   261,668   Morgan Stanley
GBP   371,896,882   USD   544,776,495   6/30/2016   6,009,601   Morgan Stanley
HKD   1,071,988,780   USD   138,058,889   6/30/2016   44,060   Morgan Stanley
JPY   44,582,684,192   USD   404,717,042   6/30/2016   1,635,397   Morgan Stanley
SEK   271,597,731   USD   32,708,616   6/30/2016   104,237   Morgan Stanley
Total unrealized appreciation             8,412,168    
Contracts to Deliver   In Exchange For   Settlement
Date
   Unrealized
Depreciation ($)
   Counterparty
JPY   454,432,083   USD   4,089,909   6/30/2016   (18,709)  Morgan Stanley
SGD   90,944,335   USD   65,827,096   6/30/2016   (178,388)  Morgan Stanley
Total unrealized depreciation               (197,097)   

 

Currency Abbreviations
CHF Swiss Franc    
EUR Euro    
GBP British Pound    
HKD Hong Kong Dollar    
JPY Japanese Yen    
SEK Swedish Krona    
SGD Singapore Dollar    
USD United States Dollar    

 

At May 31, 2016 the Deutsche CROCI International Fund had the following sector diversification:
Sector Diversification Market Value ($)   As a % of Common Stocks  
Consumer Discretionary   518,428,180   30.2 %  
Industrials   513,031,907   29.8 %  
Utilities   343,327,743   20.0 %  
Health Care   139,207,063   8.1 %  
Materials   103,456,012   6.0 %  
Information Technology   66,372,235   3.9 %  
Consumer Staples   34,339,459   2.0 %  
Total 1,718,162,599   100.0 %  
Sector diversification is subject to change.
                 

 

Fair Value Measurements

 

Various inputs are used in determining the value of the Fund's investments. These inputs are summarized in three broad levels. Level 1 includes quoted prices in active markets for identical securities. Level 2 includes other significant observable inputs (including quoted prices for similar securities, interest rates, prepayment speeds, and credit risk). Level 3 includes significant unobservable inputs (including the Fund's own assumptions in determining the fair value of investments).The level assigned to the securities valuations may not be an indication of the risk or liquidity associated with investing in those securities.

 

The following is a summary of the inputs used as of May 31, 2016 in valuing the Fund's investments.

Assets   Level 1   Level 2   Level 3   Total
Common Stocks                
  France $ $ 65,756,549 $ $ 65,756,549
  Germany     68,760,199     68,760,199
  Hong Kong     137,046,445     137,046,445
  Japan     413,525,765     413,525,765
  Netherlands     33,490,237     33,490,237
  Singapore     64,981,350     64,981,350
  Spain     66,002,960     66,002,960
  Sweden     32,422,067     32,422,067
  Switzerland     337,908,636     337,908,636
  United Kingdom   450,757   497,817,634     498,268,391
Short-Term Investments (d)   45,144,122       45,144,122
Derivatives (e)                
  Forward Foreign Currency Exchange Contracts $ $ 8,412,168 $ $ 8,412,168
Total $ 45,594,879 $ 1,726,124,010 $ $ 1,771,718,889
Liabilities   Level 1   Level 2   Level 3   Total
Derivatives (e)                
  Forward Foreign Currency Exchange Contracts $ $ (197,097) $ $ (197,097)
Total $ $ (197,097) $ $ (197,097)

 

There have been no transfers between fair value measurement levels during the period ended May 31, 2016.

 

(d) See Investment Portfolio for additional detailed categorizations.
(e) Derivatives include value of options purchased, unrealized appreciation (depreciation) on open futures contracts, credit default swap contracts, interest rate swap contracts, forward foreign currency exchange contracts, and written options, at value.

 

Derivatives

 

The following table presents, by major type of derivative contract, the unrealized appreciation (depreciation) of the Fund's derivative instruments as of May 31, 2016 categorized by the primary underlying risk exposure. 

 

 

Primary Underlying Risk Disclosure

Forward
Currency
Contracts
Foreign Exchange Contracts   $  8,215,071

 

 

 

 

 

 

 

 

ITEM 2. CONTROLS AND PROCEDURES
   
  (a) The Chief Executive and Financial Officers concluded that the Registrant’s Disclosure Controls and Procedures are effective based on the evaluation of the Disclosure Controls and Procedures as of a date within 90 days of the filing date of this report.
   
  (b) There have been no changes in the registrant’s internal control over financial reporting that occurred during the registrant’s last fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal controls over financial reporting.
   
ITEM 3. EXHIBITS
   
  Certification pursuant to Rule 30a-2(a) under the Investment Company Act of 1940 (17 CFR 270.30a-2(a)) is filed and attached hereto as Exhibit 99.CERT.

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Registrant: Deutsche CROCI® International Fund, a series of Deutsche International Fund, Inc.
   
By:

/s/Brian E. Binder

Brian E. Binder

President

   
Date: July 22, 2016

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934 and the Investment Company Act of 1940, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

 

 

By:

/s/Brian E. Binder

Brian E. Binder

President

   
Date: July 22, 2016
   
   
   
By:

/s/Paul Schubert

Paul Schubert

Chief Financial Officer and Treasurer

   
Date: July 22, 2016

EX-99.CERT 2 ex99cert.htm CERTIFICATIONS

CERTIFICATIONS

I, Brian E. Binder, certify that:

1.I have reviewed this report on Form N-Q of Deutsche CROCI® International Fund, a series of Deutsche International Fund, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;
4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and
(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

   
By:

/s/Brian E. Binder

Brian E. Binder

President

   
Date: July 22, 2016

 

 
 

CERTIFICATIONS

I, Paul Schubert, certify that:

1.I have reviewed this report on Form N-Q of Deutsche CROCI® International Fund, a series of Deutsche International Fund, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the schedules of investments included in this report fairly present in all material respects the investments of the registrant as of the end of the fiscal quarter for which the report is filed;
4.The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Rule 30a-3(c) under the Investment Company Act of 1940) and internal control over financial reporting (as defined in Rule 30a-3(d) under the Investment Company Act of 1940) for the registrant and have:
(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of a date within 90 days prior to the filing date of this report, based on such evaluation; and
(d)Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and
5.The registrant's other certifying officer(s) and I have disclosed to the registrant's auditors and the audit committee of the registrant's board of directors (or persons performing the equivalent functions):
(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize, and report financial information; and
(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

 

   
By:

/s/Paul Schubert

Paul Schubert

Chief Financial Officer and Treasurer

   
Date: July 22, 2016